|
Mr. Brand brings 16 years of pharmaceutical experience with 11 years Neuroscience experience. As VP, Global Commercial Strategy Neuroscience, GlaxoSmithKline PLC (GSK), Mr. Brand was responsible for commercial development of GSK’s phase I III Neuroscience pipeline. In addition, Mr. Brand oversaw global commercialization for marketed CNS products to include Paxil /CR, Wellbutrin /XL, Zyban, Lamictal, Imitrex and Requip. As Paxil marketing director, Mr. Brand managed GSK’s largest asset achieving gross sales of $1.8 billion and was recognized as one of Advertising Age’s Top 100 Marketers (2000). An experienced executive, Mr. Brand has managed multiple co-promotions / co-development partnerships and brings extensive lifecycle management and market development experience | 